Overview

Acute and Residual Effects of Caffeinated Beer

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to develop information about the acute and residual effects of a new product being targeted to young adults. Using a double placebo-controlled 2 X 2 factorial model study design, we will compare the acute and residual effects on driving impairment of caffeinated alcohol, non-caffeinated alcohol, caffeinated placebo, and non-caffeinated placebo. Under the alcohol conditions, participants will receive sufficient alcoholic beverage to attain a blood alcohol concentration (BAC) of .12 g%. Participants will be 144 undergraduate and graduate students, and recent college graduates.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Boston University
Collaborators:
Brown University
Centers for Disease Control and Prevention
University of Michigan
Treatments:
Caffeine
Ethanol
Methamphetamine